CSF1 and central nervous system cancer: Immunoblot analysis confirmed that glioma-CM remarkedly increased IL-6 expression and moderately increased CSF-1 expression in ECs (Fig. 3b), and also showed that GBM-associated ECs constitutively expressed IL-6 and CSF-1 at a higher level than normal brain ECs (Fig. 3c).